GREM1 and colorectal carcinoma: We found that, both in mouse and human CRC, Grem1/GREM1+ CAFs were distinct from Islr/ISLR+ CAFs and that αSMA positivity was higher in Grem1/GREM1+ CAFs than Islr/ISLR+ CAFs (Figure 4A–G).